Ensysce Biosciences, Inc. logo

Ensysce Biosciences, Inc. (ENSC) Q1 2025 Earnings

ENSC·Reported May 13, 2025·Before market open

Ensysce Biosciences, Inc. reported Q1 2025 revenue of $1.3M (+331.8% YoY). Diluted EPS came in at $-1.39 (+83.2% YoY), beat the $-3.02 consensus by $1.63.

Revenue
$1.3M
Diluted EPS
$-1.39beat by $1.63
Consensus: $-3.02
SEC

SEC Filings

Earnings release8-K not filed yet
Quarterly report10-Q · 0001641172-25-009955

Financial Snapshot

Trailing eight quarters through Q1 2025

View all metrics

Revenue

View metric

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric

Q1 2025 Earnings FAQ

Common questions about Ensysce Biosciences, Inc.'s Q1 2025 earnings report.

Ensysce Biosciences, Inc. (ENSC) reported Q1 2025 earnings on May 13, 2025 before market open.

Ensysce Biosciences, Inc. reported revenue of $1.3M and diluted EPS of $-1.39 for Q1 2025.

EPS beat the consensus estimate of $-3.02 by $1.63.

Compared to the same quarter a year prior, revenue grew 331.8% from $305.7K a year earlier and diluted EPS grew 83.2% from $-8.25.

You can read the 10-Q periodic report (0001641172-25-009955) directly on SEC EDGAR. The filing index links above go to sec.gov.